Google
Apple
English (UK)
English (India)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
MYUNGMOON PHARM CO.,LTD |
End-of-day quote
Other stock markets
|
|
5-day change | 1st Jan Change | |
| 2,440 KRW | -0.41% | +12.70% | -14.98% | |
| Sales 2022 | 152B 115M | Sales 2023 * | - | Capitalization | 97.02B 73.54M |
|---|---|---|---|---|---|
| Net income 2022 | 7.87B 5.96M | Net income 2023 * | - | EV / Sales 2022 | 1,12x |
| Net Debt 2022 | 73.17B 55.46M | Net cash position 2023 * | - 0 | EV / Sales 2023 * | - |
| P/E ratio 2022 | 12,3x | P/E ratio 2023 * | Employees | 283 | |
| Yield 2022 | - | Yield 2023 * |
-
| Free-Float | 78.44% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.41% | ||
| 1 week | +12.70% | ||
| Current month | +12.18% | ||
| 1 month | +5.86% | ||
| 3 months | +1.04% | ||
| 6 months | -9.29% | ||
| Current year | -14.98% |
1 week
2 140.00
2 685.00
1 month
2 135.002 685.00
Current year
1 962.003 180.00
1 year
1 962.003 450.00
3 years
1 962.0011 750.00
5 years
1 962.0011 750.00
10 years
1 758.7411 750.00
| Managers | Title | Age | Since |
|---|---|---|---|
Choon-Sik Park
CEO | Chief Executive Officer | 61 | - |
Seok-Min Woo
CHM | Chairman | 55 | 2001 |
Jang-Ho Lee
CTO | Chief Tech/Sci/R&D Officer | 51 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Seok-Min Woo
CHM | Chairman | 55 | 2001 |
Yong-Jin Jeong
BRD | Director/Board Member | 58 | - |
Cheol-Han Bae
BRD | Director/Board Member | 71 | - |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 5,201 M€ | +8.38% | - | |
| 0.00% | 2,233 M€ | +6.46% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23-12-08 | 2,440 | -0.41% | 294,827 |
| 23-12-07 | 2,450 | +5.83% | 933,018 |
| 23-12-06 | 2,315 | -0.64% | 2,226,575 |
| 23-12-05 | 2,330 | +8.12% | 651,136 |
| 23-12-04 | 2,155 | -0.46% | 40,142 |
End-of-day quote Korea Stock Exchange, December 07, 2023
More quotes
MyungMoon Pharm. Co., Ltd. is a Korea-based company mainly engaged in the manufacture of pharmaceuticals. Its products include ethical (ETC) drugs and over the counter (OTC) drugs. Its ETC drugs include anesthetic agents, digestive system drugs, rheumatoid arthritis remedies, central nervous system drugs, circulatory drugs, anti-depressant agents, anti-diabetic agents, antibiotics, hormone agents, narcotics and drugs for dermatology systems. Its OTC drugs include antinauseant agents, hepatic agents, immunologic agents, antidiarrheal agents, skin external preparations, antiallergic agents, muscle relaxants, cold drugs and parasiticides. The Company is also involved in the operation golf courses. January 2, 2012, the Company completed the merger with its wholly owned subsidiary.
Sector
Pharmaceuticals
Calendar
2024-03-21
- Q4 2023 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -14.98% | 62 M $ | |
| +63.47% | 538 B $ | |
| +42.56% | 430 B $ | |
| -12.58% | 372 B $ | |
| -7.63% | 264 B $ | |
| -6.49% | 263 B $ | |
| -12.81% | 232 B $ | |
| +1.35% | 198 B $ | |
| -9.77% | 197 B $ | |
| -43.83% | 163 B $ |
